NEW YORK, Nov. 12, 2020 /PRNewswire/ -- Halper Sadeh LLP, a global investor rights law firm, announces it is investigating:

(PRNewsfoto/Halper Sadeh LLP)

CIT Group Inc. (NYSE: CIT) concerning potential violations of the federal securities laws and/or breaches of fiduciary duties relating to its sale to First Citizens BancShares, Inc. Under the terms of the merger agreement, CIT shareholders will receive 0.0620 shares of First Citizens class A common stock for each share of CIT common stock they own. If you are a CIT Group shareholder, click on this link to learn more about your legal rights and options: https://halpersadeh.com/actions/cit-group-inc-stock-merger-first-citizens/.

Concho Resources Inc. (NYSE: CXO) concerning potential violations of the federal securities laws and/or breaches of fiduciary duties relating to its sale to ConocoPhillips. Under the terms of the merger, Concho shareholders will receive 1.46 shares of ConocoPhillips common stock for each share of Concho common stock they own. If you are a Concho shareholder, click on this link to learn more about your rights and options: https://halpersadeh.com/actions/concho-resources-inc-stock-merger-conocophillips.

BioSpecifics Technologies Corp. (NASDAQ: BSTC) concerning potential violations of the federal securities laws and/or breaches of fiduciary duties relating to its sale to Endo International plc for $88.50 per share. If you are a BioSpecifics shareholder, click on this link to learn more about your rights and options: https://halpersadeh.com/actions/biospecifics-technologies-corp-stock-merger-endo-international.

Cleveland BioLabs, Inc. (NASDAQ: CBLI) concerning potential violations of the federal securities laws and/or breaches of fiduciary duties relating to its merger with Cytocom, Inc. Under the merger, Cleveland BioLabs stockholders are expected to own approximately 39% of the combined company. If you are a Cleveland BioLabs shareholder, click on this link to learn more about your rights and options: https://halpersadeh.com/actions/cleveland-biolabs-inc-cbli-stock-merger/.

PNM Resources, Inc. (NYSE: PNM) concerning potential violations of the federal securities laws and/or breaches of fiduciary duties relating to its sale to Avangrid, Inc. for $50.30 in cash per share. If you are a PNM Resources shareholder, click on this link to learn more about your rights and options:  https://halpersadeh.com/actions/pnm-resources-inc-stock-merger-avangrid/.

Halper Sadeh LLP may seek increased consideration, additional disclosures and information concerning the proposed transaction, or other relief and benefits on behalf of shareholders.

Shareholders are encouraged to contact the firm free of charge to discuss their legal rights and options. Please call Daniel Sadeh or Zachary Halper at (212) 763-0060 or email sadeh@halpersadeh.com or zhalper@halpersadeh.com.

Halper Sadeh LLP represents investors all over the world who have fallen victim to securities fraud and corporate misconduct. Our attorneys have been instrumental in implementing corporate reforms and recovering millions of dollars on behalf of defrauded investors.

Attorney Advertising. Prior results do not guarantee a similar outcome.

Contact Information:
Halper Sadeh LLP
Daniel Sadeh, Esq.
Zachary Halper, Esq.
(212) 763-0060
sadeh@halpersadeh.com 
zhalper@halpersadeh.com  
https://www.halpersadeh.com

Cision View original content to download multimedia:http://www.prnewswire.com/news-releases/investigation-alert-halper-sadeh-llp-reminds-shareholders-about-its-ongoing-merger-investigations-investors-are-encouraged-to-contact-the-firm--cit-cxo-bstc-cbli-pnm-301172225.html

SOURCE Halper Sadeh LLP